JP2002521318A5 - - Google Patents

Download PDF

Info

Publication number
JP2002521318A5
JP2002521318A5 JP2000560859A JP2000560859A JP2002521318A5 JP 2002521318 A5 JP2002521318 A5 JP 2002521318A5 JP 2000560859 A JP2000560859 A JP 2000560859A JP 2000560859 A JP2000560859 A JP 2000560859A JP 2002521318 A5 JP2002521318 A5 JP 2002521318A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000560859A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002521318A (ja
JP4719356B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/016630 external-priority patent/WO2000004866A2/en
Publication of JP2002521318A publication Critical patent/JP2002521318A/ja
Publication of JP2002521318A5 publication Critical patent/JP2002521318A5/ja
Application granted granted Critical
Publication of JP4719356B2 publication Critical patent/JP4719356B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000560859A 1998-07-23 1999-07-23 抗ガン剤及びdna複製阻害剤 Expired - Fee Related JP4719356B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9386998P 1998-07-23 1998-07-23
US60/093,869 1998-07-23
PCT/US1999/016630 WO2000004866A2 (en) 1998-07-23 1999-07-23 Preparation of thioarabinofuranosyl compounds and use thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010102499A Division JP2010202655A (ja) 1998-07-23 2010-04-27 チオアラビノフラノシル化合物の製造方法
JP2010243705A Division JP5357857B2 (ja) 1998-07-23 2010-10-29 抗ガン剤及びdna複製阻害剤

Publications (3)

Publication Number Publication Date
JP2002521318A JP2002521318A (ja) 2002-07-16
JP2002521318A5 true JP2002521318A5 (https=) 2011-01-20
JP4719356B2 JP4719356B2 (ja) 2011-07-06

Family

ID=22241386

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2000560859A Expired - Fee Related JP4719356B2 (ja) 1998-07-23 1999-07-23 抗ガン剤及びdna複製阻害剤
JP2010102499A Pending JP2010202655A (ja) 1998-07-23 2010-04-27 チオアラビノフラノシル化合物の製造方法
JP2010243705A Expired - Lifetime JP5357857B2 (ja) 1998-07-23 2010-10-29 抗ガン剤及びdna複製阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2010102499A Pending JP2010202655A (ja) 1998-07-23 2010-04-27 チオアラビノフラノシル化合物の製造方法
JP2010243705A Expired - Lifetime JP5357857B2 (ja) 1998-07-23 2010-10-29 抗ガン剤及びdna複製阻害剤

Country Status (9)

Country Link
US (5) US6576621B1 (https=)
EP (3) EP1100512B1 (https=)
JP (3) JP4719356B2 (https=)
AT (1) ATE531376T1 (https=)
AU (1) AU747012B2 (https=)
CA (1) CA2338415C (https=)
ES (3) ES2376862T3 (https=)
NZ (1) NZ509405A (https=)
WO (1) WO2000004866A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338415C (en) * 1998-07-23 2006-10-10 Southern Research Institute Preparation of thioarabinofuranosyl compounds and use thereof
WO2004018494A1 (ja) * 2002-08-22 2004-03-04 Geneticlab Co., Ltd. 4’−チオヌクレオチド
US7524831B2 (en) * 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
KR101582570B1 (ko) * 2007-03-23 2016-01-06 써던 리서취 인스티튜트 관절염 치료 및 예방 방법
AR064165A1 (es) 2007-12-06 2009-03-18 Richmond Sa Com Ind Y Financie Un procedimiento para la preparacion de capecitabina e intermediarios utilizables en dicho procedimiento
EP2303226B1 (en) * 2008-06-25 2016-03-23 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
US20110218170A1 (en) * 2010-03-02 2011-09-08 Southern Research Institute Use of 2'-deoxy-4'-thiocytidine and its analogues as dna hypomethylating anticancer agents
SG10201603288XA (en) 2012-03-28 2016-05-30 Fujifilm Corp Salt Of 1-(2-Deoxy-2-Fluoro-4-Thio-beta-D-Arabinofuranosyl)Cytosine
JP6351107B2 (ja) * 2014-02-18 2018-07-04 富士フイルム株式会社 チオラン骨格型糖化合物の製造方法およびチオラン骨格型糖化合物
EP3109245B1 (en) 2014-02-18 2018-01-03 FUJIFILM Corporation Method for producting thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate
JP6245527B2 (ja) * 2014-03-24 2017-12-13 富士フイルム株式会社 チオラン環もしくはチアン環骨格を有する化合物の製造方法
TWI678373B (zh) 2014-10-31 2019-12-01 日商富士軟片股份有限公司 硫代核苷衍生物或其鹽及醫藥組合物
US10815264B2 (en) * 2015-05-27 2020-10-27 Southern Research Institute Nucleotides for the treatment of cancer
WO2017091836A1 (en) * 2015-11-25 2017-06-01 University Of South Carolina Enhancement of cytarabine activity by inhibiting cdk8/19
IL265044B2 (en) 2016-08-31 2025-02-01 Fujifilm Corp An antitumor preparation containing the substances nab-paclitaxel and 1-(2-deoxy-2-fluoro-4-thio-D-beta-arabinofurnosyl)cytosine, a kit containing these substances and their uses
WO2019146130A1 (ja) 2018-01-29 2019-08-01 富士フイルム株式会社 胆道がん用抗腫瘍剤および胆道がんの処置方法
WO2019204637A1 (en) * 2018-04-19 2019-10-24 Southern Research Institute 4'-thio-nucleotide and -nucleoside prodrugs for the treatment of cancer
EP3993806A4 (en) * 2019-06-05 2023-09-13 Southern Research Institute Thiarabine- and thiarabine prodrug-based treatments
EP4138843A4 (en) 2020-04-23 2024-07-10 Southern Research Institute COMPOSITION FOR THE TREATMENT OF BLOOD CANCER USING 4'-THIO-5-AZA-2'-DEOXYCYTIDINE AND USES THEREOF

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6401490A (en) * 1989-09-15 1991-04-18 Southern Research Institute 2'-deoxy-4'-thioribonucleosides as antiviral and anticancer agents
IE74701B1 (en) * 1989-10-04 1997-07-30 Univ Birmingham Further antiviral pyrimidine nucleosides
JPH04505929A (ja) * 1989-12-08 1992-10-15 シティ・オブ・ホープ ヒトの抗癌剤の耐性の回避
JPH09249690A (ja) 1995-07-14 1997-09-22 Yamasa Shoyu Co Ltd 4’−チオアラビノプリンヌクレオシド
JPH0925289A (ja) 1995-07-14 1997-01-28 Yamasa Shoyu Co Ltd 4’−チオアラビノピリミジンヌクレオシドの製造方法
JP2943690B2 (ja) 1996-04-17 1999-08-30 日本電気株式会社 セル衝突検出装置
AU749561B2 (en) 1997-05-09 2002-06-27 Ribozyme Pharmaceuticals, Inc. Nucleic acid molecules having endonuclease and/or catalytic activity
US6548657B1 (en) * 1997-06-09 2003-04-15 Ribozyme Pharmaceuticals, Inc. Method for screening nucleic acid catalysts
WO1999043690A1 (en) 1998-02-25 1999-09-02 Rational Drug Design Laboratories L-4'-arabinofuranonucleoside compound and medicine composition comprising the same
CA2338415C (en) * 1998-07-23 2006-10-10 Southern Research Institute Preparation of thioarabinofuranosyl compounds and use thereof

Similar Documents

Publication Publication Date Title
JP2002532892A5 (https=)
JP2002501108A5 (https=)
JP2001517423A5 (https=)
JP2003520279A5 (https=)
JP2000133215A5 (https=)
JP2002540767A5 (https=)
JP2000052899A5 (https=)
JP2001015154A5 (https=)
JP2000343526A5 (https=)
JPH11140398A5 (https=)
JP2002521318A5 (https=)
JP2002536520A5 (https=)
JP2000252171A5 (https=)
JP2002029946A5 (https=)
JPH11303709A5 (https=)
JP2001131407A5 (https=)
JP2001100043A5 (https=)
JP2000275740A5 (https=)
JP2001514219A5 (https=)
JP2001000144A5 (https=)
JP2000303131A5 (https=)
JP2002097406A5 (https=)
JP2002502840A5 (https=)
JP2000017519A5 (https=)
JPH11228602A5 (https=)